Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
4.030
+0.050 (1.26%)
At close: Jul 3, 2025, 1:00 PM
4.085
+0.055 (1.36%)
After-hours: Jul 3, 2025, 1:00 PM EDT
Nephros Market Cap
Nephros has a market cap or net worth of $42.72 million as of July 3, 2025. Its market cap has increased by 92.43% in one year.
Market Cap
42.72M
Enterprise Value
39.97M
1-Year Change
92.43%
Ranking
Category
Stock Price
$4.03
Market Cap Chart
Since August 15, 2019, Nephros's market cap has decreased from $54.10M to $42.72M, a decrease of -21.04%. That is a compound annual growth rate of -3.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 42.70M | 175.48% |
| Dec 31, 2024 | 15.50M | -57.30% |
| Dec 29, 2023 | 36.30M | 205.04% |
| Dec 30, 2022 | 11.90M | -80.30% |
| Dec 31, 2021 | 60.40M | -28.61% |
| Dec 31, 2020 | 84.60M | 6.82% |
| Dec 31, 2019 | 79.20M | 46.40% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |